Davy Asset Management Ltd Invests $1.44 Million in Hologic, Inc. (HOLX)

Share on StockTwits

Davy Asset Management Ltd bought a new stake in Hologic, Inc. (NASDAQ:HOLX) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 46,616 shares of the medical equipment provider’s stock, valued at approximately $1,444,000.

Several other institutional investors have also recently bought and sold shares of HOLX. Raymond James & Associates grew its position in Hologic by 13.7% during the second quarter. Raymond James & Associates now owns 101,016 shares of the medical equipment provider’s stock worth $4,015,000 after buying an additional 12,191 shares in the last quarter. BB&T Securities LLC grew its position in Hologic by 11.9% during the second quarter. BB&T Securities LLC now owns 153,314 shares of the medical equipment provider’s stock worth $6,094,000 after buying an additional 16,329 shares in the last quarter. Flinton Capital Management LLC grew its position in Hologic by 18.9% during the second quarter. Flinton Capital Management LLC now owns 26,928 shares of the medical equipment provider’s stock worth $1,071,000 after buying an additional 4,284 shares in the last quarter. Rampart Investment Management Company LLC grew its position in Hologic by 103.0% during the second quarter. Rampart Investment Management Company LLC now owns 22,642 shares of the medical equipment provider’s stock worth $900,000 after buying an additional 11,489 shares in the last quarter. Finally, Osterweis Capital Management Inc. grew its position in Hologic by 23.1% during the second quarter. Osterweis Capital Management Inc. now owns 818,625 shares of the medical equipment provider’s stock worth $32,540,000 after buying an additional 153,520 shares in the last quarter. 98.66% of the stock is currently owned by institutional investors.

NASDAQ HOLX opened at $38.74 on Friday. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.29 and a quick ratio of 0.99. Hologic, Inc. has a fifty-two week low of $35.10 and a fifty-two week high of $45.09. The firm has a market cap of $10.62 billion, a price-to-earnings ratio of 19.08, a price-to-earnings-growth ratio of 1.78 and a beta of 0.65.

Hologic (NASDAQ:HOLX) last released its earnings results on Tuesday, July 31st. The medical equipment provider reported $0.58 earnings per share for the quarter, topping the consensus estimate of $0.56 by $0.02. Hologic had a positive return on equity of 22.18% and a negative net margin of 2.47%. The firm had revenue of $824.00 million during the quarter, compared to analysts’ expectations of $800.14 million. analysts predict that Hologic, Inc. will post 2.24 EPS for the current fiscal year.

A number of brokerages recently issued reports on HOLX. Needham & Company LLC increased their price target on Hologic from $43.00 to $48.00 and gave the stock a “buy” rating in a research report on Wednesday, August 1st. BidaskClub raised Hologic from a “hold” rating to a “buy” rating in a research report on Wednesday, August 1st. BTIG Research reissued a “buy” rating and set a $47.00 price target on shares of Hologic in a research report on Thursday, August 2nd. Deutsche Bank increased their price target on Hologic from $42.00 to $45.00 and gave the stock a “hold” rating in a research report on Wednesday, August 1st. Finally, Canaccord Genuity reduced their price target on Hologic from $42.00 to $41.00 and set a “hold” rating on the stock in a research report on Tuesday, August 14th. One analyst has rated the stock with a sell rating, eight have given a hold rating and eight have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $44.87.

About Hologic

Hologic, Inc develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. The company operates through five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical, and Skeletal Health.

Recommended Story: New Google Finance Tool and Screening Stocks

Want to see what other hedge funds are holding HOLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hologic, Inc. (NASDAQ:HOLX).

Institutional Ownership by Quarter for Hologic (NASDAQ:HOLX)

Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply